Koi Biotherapeutics
Biotechnology Research
21 employees
- Employees
- 21
- Contacts
- 1
- Emails
- 1
- Phones
- 1
Koi Biotherapeutics Overview
- Website
- www.koibiotherapeutics.com
- Industry
- Biotechnology Research
- Employees
- 21
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Koi Biotherapeutics
Our venture is focused on solving a fundamental challenge in CAR T-cell therapy - the lack of long-term persistence of CAR T-cells post-infusion. We have developed a novel CAR-Enhancer platform that leverages a proprietary protein to selectively promote the generation of memory CAR T-cells, enhancing their activity and in vivo persistence. Our solution has the potential to revolutionize CAR T-cell therapy by injecting a much lower number of CAR T-cells and eliminating the need for ex vivo expansion and lymphodepletion, and ultimately saving many lives.
Koi Biotherapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 1
- Email contacts
- 1
- 25.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Koi Biotherapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Sadik Ch | I Am 12 Cllas Paas at Koi | Baghpat, Uttar Pradesh, India |
View
|
| Sunil Sunil |
View
|
||
| Vikash Shila | No Job at Koi Biotherapeutics |
View
|
|
| Hamid Mahini | Co-founder & CEO at Koi Biotherapeutics | United States |
Email
Phone
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Compare Similar Companies to Koi Biotherapeutics
Uber
Internet Marketplace Platforms
MassBio
Biotechnology Research
Seaport Therapeutics
Biotechnology Research
Wisdomise
Financial Services
SanegeneBio
Biotechnology Research
AIR Properties
Real Estate
Cloverleaf Bio
Biotechnology Research
DoriNano
Biotechnology Research
NuCyRNA Therapeutics
Biotechnology Research
Koi Therapeutics
Pharmaceutical Manufacturing